Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Total 13F shares
-
6,160,435
-
Share change
-
-146,026
-
Total reported value
-
$41,582,505
-
Price per share
-
$6.75
-
Number of holders
-
40
-
Value change
-
-$1,002,295
-
Number of buys
-
20
-
Number of sells
-
7
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q4 2016
As of 31 Dec 2016,
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,160,435 shares.
The largest 10 holders included
FMR LLC, JPMORGAN CHASE & CO, STIFEL FINANCIAL CORP, BlackRock Fund Advisors, VANGUARD GROUP INC, Lombard Odier Asset Management (USA) Corp, STATE STREET CORP, Allianz Asset Management GmbH, NORTHERN TRUST CORP, and MILLENNIUM MANAGEMENT LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.